NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-001-2016-0-IL-12 Anti-CD30 Chimeric Antigen Receptors IL ORD 258527 Abandoned
NCI E-174-2018-2-US-02 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US National Stage 15/947,688 10912797 Issued PDF
NICHD E-093-2017-0-PCT-02 ISOTROPIC GENERALIZED DIFFUSION TENSOR MRI PCT PCT PCT/US2018/026584 Expired
NCI E-001-2016-0-BR-04 ANTI-CD30 CHIMERIC ANTIGEN RECEPTORS BR National Stage BR112018006995-7 Abandoned
NCI E-035-2017-0-MX-15 STAT3 INHIBITOR FORMULATION MX National Stage MX/a/2019/011913 Abandoned
NCI E-035-2017-0-NL-23 STAT3 INHIBITOR FORMULATION NL EP 18720845.9 Abandoned
NCI E-035-2017-0-PL-24 STAT3 INHIBITOR FORMULATION PL EP 18720845.9 Abandoned
NCI E-035-2017-0-IT-22 STAT3 INHIBITOR FORMULATION IT EP 18720845.9 Abandoned
NCI E-035-2017-0-SE-25 STAT3 INHIBITOR FORMULATION SE EP 18720845.9 Abandoned
NCI E-035-2017-0-ES-19 STAT3 INHIBITOR FORMULATION ES EP 18720845.9 Abandoned
NCI E-035-2017-0-FR-20 STAT3 INHIBITOR FORMULATION FR EP 18720845.9 Abandoned
NCI E-035-2017-0-DE-18 STAT3 INHIBITOR FORMULATION DE EP 18720845.9 Abandoned
NCI E-035-2017-0-EP-09 STAT3 INHIBITOR FORMULATION EP National Stage 18720845.9 Abandoned
NCI E-035-2017-0-GB-21 STAT3 INHIBITOR FORMULATION GB EP 18720845.9 Abandoned
NCI E-035-2017-0-PCT-02 STAT3 INHIBITOR FORMULATION PCT PCT PCT/US2018/026228 Expired
NCI E-035-2017-0-JP-13 STAT3 INHIBITOR FORMULATION JP National Stage 2019-555108 Abandoned
NCI E-035-2017-0-IN-12 STAT3 INHIBITOR FORMULATION IN National Stage 201917044212 Abandoned
NCI E-035-2017-0-CL-06 STAT3 INHIBITOR FORMULATION CL National Stage 02843-2019 Pending
NCI E-035-2017-0-CA-05 STAT3 INHIBITOR FORMULATION CA National Stage 3058973 Abandoned
NCI E-035-2017-0-CO-08 STAT3 INHIBITOR FORMULATION CO National Stage NC2019/012386 Pending
NCI E-035-2017-0-KR-14 STAT3 INHIBITOR FORMULATION KR National Stage 10-2019-7032793 Pending
NCI E-035-2017-0-PE-16 STAT3 INHIBITOR FORMULATION PE National Stage 1997-2019 Pending
NCI E-035-2017-0-AU-03 STAT3 INHIBITOR FORMULATION AU National Stage 2018248303 Abandoned
NCI E-035-2017-0-BR-04 STAT3 INHIBITOR FORMULATION BR National Stage BR112019020985-9 Abandoned
NIAID E-137-2018-2-MX-13 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response MX National Stage MX/a/2019/011888 Issued
NIAID E-137-2018-2-AU-03 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response AU National Stage 2018250226 Issued
NIAID E-137-2018-2-EA-07 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response EA National Stage 201992367 Issued
NIAID E-137-2018-2-PCT-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response PCT PCT COMB PCT/US2018/026145 Expired
NCATS E-130-2017-0-PCT-02 COMBINATION THERAPY FOR TREATING CANCER PCT PCT PCT/US2018/026106 Expired
NIAID E-137-2018-2-CN-06 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response CN National Stage 201880030232.8 Pending
NIAID E-137-2018-2-EP-08 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response EP National Stage 18724006.4 Pending
NIAID E-137-2018-2-JP-11 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response JP National Stage 2019-555006 Abandoned
NIAID E-137-2018-2-CA-05 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response CA National Stage 3057715 Pending
NIAID E-137-2018-2-BR-04 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response BR National Stage BR1120190208534 Pending
NIAID E-137-2018-2-IN-10 PEPTIDE-BASED VACCINES METHODS OF MANUFACTURING AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE IN National Stage 201917040040 Pending
NIAID E-137-2018-2-EA-01 PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE EA DIV 202393052 Pending
NHLBI E-273-2015-0-GB-08 Endo-cameral Closure Device GB EP 16852768.7 Issued
NHLBI E-273-2015-0-EP-03 Endo-cameral Closure Device EP National Stage 16852768.7 Issued
NHLBI E-273-2015-0-IE-09 Endo-cameral Closure Device IE EP 16852768.7 Issued
NHLBI E-273-2015-0-FR-07 Endo-cameral Closure Device FR EP 16852768.7 Issued
NHLBI E-273-2015-0-DE-06 Endo-cameral Closure Device DE EP 16852768.7 Issued
NHLBI E-273-2015-0-CH-05 Endo-cameral Closure Device CH EP 16852768.7 Issued
NHLBI E-287-2015-2-EP-04 Devices And Methods For Effectuating Percutaneous Glenn And Fontan Procedures EP National Stage 16847336.1 Issued
NCI E-277-2016-0-PCT-02 Functionally-interdependent Shape-switching Nucleic Acid Nanoparticles PCT PCT PCT/US2018/025953 Expired
NIAID E-031-2026-0-US-01 Antigenic Epstein Barr Virus Polypeptides US 62/652,201 Expired
NHLBI E-165-2015-2-US-01 LENTIVIRAL PROTEIN DELIVERY SYSTEM FOR RNA-GUIDED GENOME EDITING US CIP 15/942,673 11203768 Issued PDF
NCI E-237-2016-0-PCT-02 EXPRESSION CASSETTES AND METHODS FOR DETECTING TRANSCRIPTION ERRORS PCT PCT PCT/US2018/025701 Expired
NHLBI E-078-2019-0-US-01 HELICAL GUIDEWIRES AND RELATED SYSTEMS US 62/651,692 Abandoned
NCI E-040-2012-0-RU-26 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen RU DIV 2018111462 Issued
NCI E-171-2017-0-PCT-02 B CELL DISORDER CLASSIFICATION AND SUSCEPTIBILITY TO INHIBITORS PCT PCT PCT/US2018/025377 Expired